Philippines National Health Plan Urged To Subsidize Drugs For Poor
This article was originally published in PharmAsia News
Executive SummaryThe Philippines' state-run Health Insurance Corp. is been pressured to subsidize prescription drugs, particularly on an out-patient basis for the nation's poor
You may also be interested in...
CES 2020: Panel Discusses Health Care In 2040 – Empowered Consumer, Digital Transformation, Data Sharing, Open Source
AveXis President David Lennon talked to Pink Sheet about quality enhancement at the gene therapy unit, a clinical trial hold for Zolgensma in Type 2 SMA, and expansion in gene therapy.
With business heavily dependent on sales revenue from Medicare Part D and other US government programs, Lilly will be expected to narrow the gap between US prescription and sales growth.